Showing 11,001 - 11,007 results of 11,007 for search '(((( data using algorithm ) OR ( data processing algorithm ))) OR ( elemental learning algorithm ))', query time: 0.46s Refine Results
  1. 11001

    Image 1_Safety assessment of temozolomidee: real-world adverse event analysis from the FAERS database.png by Yu Liu (6938)

    Published 2025
    “…Background<p>Temozolomidee (TMZ) is an alkylating antitumor drug used in the treatment of glioblastoma and anaplastic astrocytoma. …”
  2. 11002

    Table 1_Identification and validation of CKAP2 as a novel biomarker in the development and progression of rheumatoid arthritis.docx by Qiongbing Zheng (4741563)

    Published 2025
    “…Differentially expressed gene (DEG) analysis, functional enrichment analysis, and weighted gene co-expression network analysis (WGCNA) identified key gene modules in RA. Machine learning algorithms were used to identify hub genes, followed by immune infiltration analysis and gene set variation analysis (GSVA). …”
  3. 11003

    Table 1_Plasma exosomal lncRNA-related signatures define molecular subtypes and predict survival and treatment response in hepatocellular carcinoma.docx by Fangmin Zhong (17415318)

    Published 2025
    “…</p>Methods<p>The transcriptomic data from 230 plasma exosomes and 831 HCC tissues were integrated. …”
  4. 11004

    Table 2_A real−world pharmacovigilance study of FDA Adverse Event Reporting System events for pralsetinib.xlsx by Yi Yin (448434)

    Published 2024
    “…</p>Conclusion<p>Our pharmacovigilance analysis of real-world data from the FEARS database revealed the safety signals and potential risks of pralsetinib usage. …”
  5. 11005

    Table 3_A real−world pharmacovigilance study of FDA Adverse Event Reporting System events for pralsetinib.xlsx by Yi Yin (448434)

    Published 2024
    “…</p>Conclusion<p>Our pharmacovigilance analysis of real-world data from the FEARS database revealed the safety signals and potential risks of pralsetinib usage. …”
  6. 11006

    Table 1_A real−world pharmacovigilance study of FDA Adverse Event Reporting System events for pralsetinib.docx by Yi Yin (448434)

    Published 2024
    “…</p>Conclusion<p>Our pharmacovigilance analysis of real-world data from the FEARS database revealed the safety signals and potential risks of pralsetinib usage. …”
  7. 11007

    <b>Neural Symbolic Vault: Symbolic Species and</b> <b>DNA Co-Encoding Research Bundle v1.0 (A+M[S] Archive)</b> by Jeffrey Siergiej (20937434)

    Published 2025
    “…<p dir="ltr">License Type:</p><p dir="ltr">Custom Siergiej Services IPNX License – Non-transferable, non-commercial use only unless otherwise contracted. See included LICENSE.txt for terms.…”